Benzinga | Nov 17, 2021 07:14AM EST

Evogene Q3 EPS $(0.19) Misses $(0.17) Estimate, Sales $151.00K Miss $270.00K Estimate

Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.17) by 11.76 percent. This is a 11.76 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $151.00 thousand which missed the analyst consensus estimate of $270.00 thousand by 44.07 percent. This is a 52.22 percent decrease over sales of $316.00 thousand the same period last year.